glp 1 hot flashes and GLP-1: Insights from an Expert Tirzepatide and Hot Flashes: Causes,

Understanding the leptin induced suppression of GLP1 inputs to the hypothalamus during weight gain and/or in the obese state may provide an additional pathology of obesity and diabetes

Now, research has shown that GLP-1 in higher dosages signals a feeling of fullness to cause significant weight loss and reduce the risk of cancer, diabetes, and heart disease in overweight individuals

The key difference is how the medication enters your body: Injections are absorbed directly into the bloodstream Pills must be absorbed through the stomach and intestines This difference plays a major role in how effective the medication can be

Research shows that the weight-loss average with semaglutide 2.4 mg (Wegovy) is about 15% of your starting weight